- Category
- Micro (2021-22)
- Udyam number
- UDYAM-WB-06-0008514

Curentis Biotech Private Limited
About Curentis Biotech Private Limited
Data last updated:
Curentis Biotech Private Limited is a private limited company based in Siliguri, West Bengal, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 16 February 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85190WB2022PTC251681. Its GSTIN is 19AAKCC1098D1ZL (West Bengal).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors including Deoranjan Singh and Nayan Biswas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O. Vibha Singh 01 03 Vivekananda Road Khalpar Near Rajestan Guest House, Siliguri, West Bengal, India – 734005.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.65 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹1.07 Cr (net margin 29.4%) and EBITDA of ₹1.47 Cr (EBITDA margin 40.4%).
Curentis Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-06-0008514).
Company details
Recognitions & Rankings of Curentis Biotech
Contact details
Curentis Biotech Private Limited's registered office is in Siliguri, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O. Vibha Singh 01 03 Vivekananda Road Khalpar Near Rajestan Guest House, Siliguri, West Bengal, India – 734005
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Curentis Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curentis Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curentis Biotech Private Limited, buy the company report.
Financials of Curentis Biotech Private Limited
FY 2025 filings availableCurentis Biotech Private Limited reported revenue of ₹3.65 Cr (up 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 47% in the latest year. EBITDA rose 51% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.47 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.07 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 40.4% | |||
| Net Profit Margin | 29.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Curentis Biotech Private Limited, buy the company report.
Board of directors of Curentis Biotech Private Limited
Curentis Biotech has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharma Shamsher Basnet | Additional Director | 14 Jun 2022 | 4 Years 4 Months | Current |
| Rajasri Debbarma | Additional Director | 14 Jun 2022 | 4 Years 4 Months | Current |
| Deoranjan Singh | Director | 16 Feb 2022 | 4 Years 8 Months | Current |
| Nayan Biswas | Director | 16 Feb 2022 | 4 Years 8 Months | Current |
| Mrinmoy Paul | Director | 16 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Curentis Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SJJ Medico Private Limited | ₹3.66 Cr (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Streamline Pharma Private Limited | ₹3.66 Cr (FY 2025) | 34.0% | Jagraon, Punjab, India | |||
| Entrust Healthcare Private Limited | ₹3.66 Cr (FY 2025) | 7.0% | Ranchi, Jharkhand, India | |||
| Curentis Biotech Private Limitedthis company | ₹3.65 Cr (FY 2025) | ₹1.07 Cr | 29.4% | 47.0% | Siliguri, West Bengal, India | |
| Platinum Global Additives Private Limited | ₹3.64 Cr (FY 2025) | 71.0% | Mumbai, Maharashtra, India | |||
| Ram Agro Chemical Industries Private Limited | ₹3.64 Cr (FY 2025) | 180.0% | Ponneri, Tamil Nadu, India | |||
| Sharvik Impex (India) Private Limited | ₹3.64 Cr (FY 2025) | -19.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Curentis Biotech Private Limited, buy the company report.
Auditor
Curentis Biotech Private Limited is audited by G.S. HORA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.S. HORA & ASSOCIATES | FY 2023 | 316030E |
Shareholding
The shareholding of Curentis Biotech Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Curentis Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Curentis Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curentis Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Curentis Biotech Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Curentis Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAKCC1098D1ZL | West Bengal | Active | 01 Sep 2022 |
To see the full GST registrations and return filing status of Curentis Biotech Private Limited, buy the company report.
Recent activity
Curentis Biotech Private Limited has 5 board changes on record since 2022: 5 appointments. The latest: Dharma Shamsher Basnet was appointed as Additional Director on 14 Jun 2022.
Frequently asked questions
Curentis Biotech is an active private limited company based in Siliguri, West Bengal, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 16 February 2022 (4+ years old) and is registered under CIN U85190WB2022PTC251681.
Curentis Biotech has 5 current directors:
- Dharma Shamsher Basnet - Additional Director
- Rajasri Debbarma - Additional Director
- Deoranjan Singh - Director
- Nayan Biswas - Director
- Mrinmoy Paul - Director
The latest financial statements of Curentis Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Curentis Biotech is 19AAKCC1098D1ZL, registered in West Bengal.
The CIN (Corporate Identification Number) of Curentis Biotech is U85190WB2022PTC251681. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curentis Biotech was incorporated on 16 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Curentis Biotech by revenue are SJJ Medico Private Limited, Streamline Pharma Private Limited, Entrust Healthcare Private Limited, Platinum Global Additives Private Limited, Ram Agro Chemical Industries Private Limited and 1 more, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Dharma Shamsher Basnet was appointed as Additional Director on 14 Jun 2022. Rajasri Debbarma was appointed as Additional Director on 14 Jun 2022. Deoranjan Singh was appointed as Director on 16 Feb 2022. Curentis Biotech has 5 board changes on record in total.
Yes, Curentis Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-06-0008514).
The registered office of Curentis Biotech is at CO. Vibha Singh 01 03 Vivekananda Road Khalpar Near Rajestan Guest House, Siliguri, West Bengal, India – 734005.
Curentis Biotech operates in the chemicals and materials industry, in the chemical distribution and retail segment.

